Cargando…
Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients
BACKGROUND: Cardiac autonomic neuropathy (CAN) in diabetes is among the strongest risk markers for future global and cardiovascular mortality. The aim of this study was to analyse CAN prevalence and to compare the associations between CAN, the glycaemic control, cardiovascular risk factors, peripher...
Autores principales: | Moţăţăianu, Anca, Maier, Smaranda, Bajko, Zoltan, Voidazan, Septimiu, Bălaşa, Rodica, Stoian, Adina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112121/ https://www.ncbi.nlm.nih.gov/pubmed/30149797 http://dx.doi.org/10.1186/s12883-018-1125-1 |
Ejemplares similares
-
Autonomic and Somatic Nerve Functions in Type 2 Diabetes Mellitus Patients: Electrophysiological Aspects
por: Motataianu, Anca, et al.
Publicado: (2021) -
Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus
por: Moţăţăianu, Anca, et al.
Publicado: (2013) -
Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk
por: Stoian, Adina, et al.
Publicado: (2015) -
Severe Acute Motor Axonal Neuropathy Associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report
por: Mosora, Oana, et al.
Publicado: (2021) -
Predictors of Depression in Caucasian Patients with Amyotrophic Lateral Sclerosis in Romania
por: Anca, Motataianu, et al.
Publicado: (2020)